Last updated: 2026-10-19 11:04:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
West Pharmaceutical Services, Inc. (WST) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $381.48, with a market capitalization of $27.03B and a P/E ratio of 47.84. Over the past 52 weeks, its price has ranged from $223.83 to $390.00. This page covers its latest market performance, valuation, price trends and company information.
$27.03B | |
$384.38 | |
$475.35 | |
$7.68 | |
$384.02 | |
8.00 | |
611.92K | |
47.84 | |
$390.00 | |
$223.83 | |
0.22% | |
-- |
West Pharmaceutical Services, Inc. (WST) is trading at $381.47 in pre-market trading as of 2026-10-19 11:03:00, down 0.66% ($2.55) from the previous close of $384.02
Pre-market trading shows how investors are pricing WST before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, West Pharmaceutical Services, Inc. (WST) moved from $363.27 to $381.48, representing a gain of 5.01% ($18.21).
The stock traded between $359.49 and $390.00 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 450.44 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 94.9%
WST is currently trading at $381.48, placing it 94.9% of the way from its 52-week low of $223.83 to its 52-week high of $390.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 10800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of West Pharmaceutical Services, Inc. (WST) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.